Try our Advanced Search for more refined results
Scheinberg v. Merck & Co., Inc.
Case Number:
1:08-cv-04119
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 01, 2013
Merck Can't Duck Jury Award In Fosamax Bellwether Suit
A New York federal judge on Monday denied Merck & Co. Inc.'s attempt to wipe out a $285,000 plaintiff verdict in a bellwether trial in multidistrict litigation claiming the bone drug Fosamax causes jaw deterioration, rejecting its argument that its warning was adequate.
-
February 05, 2013
Merck Loses Final Bellwether Trial In Fosamax MDL
Merck & Co. Inc. suffered a blow during the last bellwether trial in multidistrict litigation alleging bone drug Fosamax causes jaw deterioration, as a New York federal jury ruled Tuesday that the pharmaceutical giant failed to properly warn of the treatment's risks.